344 related articles for article (PubMed ID: 11310850)
1. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
Guyton K; Bond R; Reilly C; Gilkeson G; Halushka P; Cook J
J Leukoc Biol; 2001 Apr; 69(4):631-8. PubMed ID: 11310850
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.
Maggi LB; Sadeghi H; Weigand C; Scarim AL; Heitmeier MR; Corbett JA
Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955
[TBL] [Abstract][Full Text] [Related]
4. Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production.
Ferlito M; Romanenko OG; Ashton S; Squadrito F; Halushka PV; Cook JA
J Leukoc Biol; 2001 Nov; 70(5):821-9. PubMed ID: 11698503
[TBL] [Abstract][Full Text] [Related]
5. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
Giri S; Rattan R; Singh AK; Singh I
J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
7. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
[TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells.
Takeda K; Ichiki T; Tokunou T; Iino N; Takeshita A
J Biol Chem; 2001 Dec; 276(52):48950-5. PubMed ID: 11687581
[TBL] [Abstract][Full Text] [Related]
9. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2.
Lee TS; Tsai HL; Chau LY
J Biol Chem; 2003 May; 278(21):19325-30. PubMed ID: 12642589
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages.
Kim HY; Kim JR; Kim HS
J Microbiol Biotechnol; 2008 Jun; 18(6):1170-8. PubMed ID: 18600064
[TBL] [Abstract][Full Text] [Related]
11. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
12. 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade.
Eligini S; Banfi C; Brambilla M; Camera M; Barbieri SS; Poma F; Tremoli E; Colli S
Thromb Haemost; 2002 Sep; 88(3):524-32. PubMed ID: 12353085
[TBL] [Abstract][Full Text] [Related]
13. PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages.
Porter DW; Wolfarth M; Young SH; Rao MK; Meighan T; Barger M; Andrew ME; Huffman LJ
J Toxicol Environ Health A; 2007 Dec; 70(23):1967-76. PubMed ID: 17966068
[TBL] [Abstract][Full Text] [Related]
14. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.
Huang WC; Chio CC; Chi KH; Wu HM; Lin WW
Exp Cell Res; 2002 Jul; 277(2):192-200. PubMed ID: 12083801
[TBL] [Abstract][Full Text] [Related]
15. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma.
Wilmer WA; Dixon C; Lu L; Hilbelink T; Rovin BH
Biochem Biophys Res Commun; 2001 Feb; 281(1):57-62. PubMed ID: 11178960
[TBL] [Abstract][Full Text] [Related]
16. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
Bernardo A; Levi G; Minghetti L
Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
Chen CW; Chang YH; Tsi CJ; Lin WW
J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]